PMU56 IMPACT OF FDA APPROVAL OF NEW AGENTS ON THERAPEUTIC OPTIONS FOR GENETIC VARIANTS IN PEDIATRIC TUMORS
May 1, 2020, 00:00
10.1016/j.jval.2020.04.828
https://www.valueinhealthjournal.com/article/S1098-3015(20)31016-0/fulltext
Title :
PMU56 IMPACT OF FDA APPROVAL OF NEW AGENTS ON THERAPEUTIC OPTIONS FOR GENETIC VARIANTS IN PEDIATRIC TUMORS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)31016-0&doi=10.1016/j.jval.2020.04.828
First page :
Section Title :
Open access? :
No
Section Order :
10738